ロード中...
Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions
The IDH1/2 gene mutations, ATRX loss/mutation, 1p/19q status, and MGMT promoter methylation are increasingly used as prognostic or predictive biomarkers of gliomas. However, the effect of their combination on radiation therapy outcome is discussable. Previously, we demonstrated that the IDH1 c.G395A...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133876/ https://ncbi.nlm.nih.gov/pubmed/27834917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17111876 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|